Guidance for Adma Biologics (ADMA)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2027 | N/A | N/A | $775.00M | $775.00M | = Maintained | Details |
| 2026 | N/A | N/A | $635.00M | $635.00M | = Maintained | Details |
| 2026 | N/A | N/A | $630.00M | $637.90M | = Maintained | Details |
| 2026 | N/A | N/A | $605.00M | N/A | = Maintained | Details |
| 2025 | N/A | N/A | $510.00M | $506.30M | = Maintained | Details |
| 2025 | N/A | N/A | $490.00M | N/A | = Maintained | Details |
| 2024 | N/A | N/A | $400.00M – 445.00M | $357.50M | = Maintained | Details |
| 2023 | N/A | N/A | $210.00M | $211.00M | = Maintained | Details |
| 2023 | N/A | N/A | $250.00M | $258.70M | = Maintained | Details |
